Clinical Trial Update: Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Vytorin (simvastatin/ezetimibe) 10/20 mg versus atorvastatin 20 mg on the ApoB/ApoA1 ratio in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lipitor (atorvastatin)
• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Type 2 Diabetes Mellitus Without Insulin Treatment | Phase 4 | Status: UNKNOWN